Human papillomavirus genotypes in Iranian patients with cervical cancer
Authors:
- Reza ShahsiahRSReza Shahsiah
- Morteza KhademalhosseiniMKMorteza Khademalhosseini
- Nili MehrdadNMNili Mehrdad
- Fatemeh RamezaniFRFatemeh Ramezani
- Seyed Alireza NadjiSNSeyed Alireza Nadji
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 207 (12) , 754-757
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological FindingsThe Journal of Infectious Diseases, 2010
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Molecular Diagnostics of Human PapillomavirusLaboratory Medicine, 2010
- Molecular biology of human papillomavirus infection and cervical cancerClinical Science, 2006
- Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirusBMC Clinical Pathology, 2005
- Classification of papillomavirusesVirology, 2004
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysisBritish Journal of Cancer, 2003
- High risk HPV types in southern Iranian patients with cervical cancerPathology and Oncology Research, 2003
- Invasive carcinoma of the uterine cervix in IranInternational Journal of Gynecology & Obstetrics, 1999
- The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCRJournal of General Virology, 1995